GlassScriptPhysician profile
Irina Rybalova
NPI 1386864486
$17,545.08
in general payments reported to CMS, 2019-2025
79 companies · $4,456 in 2025
The $4,456 reported for 2025 was more than what 80% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,771 · 2020: $1,049 · 2021: $487 · 2022: $1,732 · 2023: $3,220 · 2024: $2,831 · 2025: $4,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,216 · Long Term Medical Supply Or Device Loan: $1,280 · Education: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,215.53 |
| Long Term Medical Supply Or Device Loan | $1,279.73 |
| Education | $1,011.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,841.15 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,334.70 | 2019-2025 | |
| Janssen Biotech, INC. | $1,025.08 | 2019-2025 | Erleada, Carvykti, Tecvayli |
| Amgen INC. | $852.43 | 2019-2023 | Vectibix, Xgeva, Nplate |
| Astrazeneca Pharmaceuticals LP | $815.81 | 2019-2025 | Enhertu, Datroway, Lynparza |
| Pfizer INC. | $614.49 | 2019-2025 | |
| Astellas Pharma US INC | $524.46 | 2020-2024 | Padcev, Xtandi, Xospata |
| E.R. Squibb & Sons, L.L.C. | $522.30 | 2019-2025 | Opdivo, Eliquis |
| Daiichi Sankyo INC. | $461.00 | 2019-2025 | Enhertu, Injectafer |
| Myriad Genetic Laboratories, INC. | $456.70 | 2022-2024 | Myrisk, Mychoice Cdx |
| Ipsen Biopharmaceuticals, INC | $405.09 | 2019-2025 | Onivyde, Somatuline Depot |
| Gilead Sciences, INC. | $389.15 | 2021-2025 | Trodelvy |
| Incyte Corporation | $384.54 | 2019-2025 | Jakafi, Pemazyre, Monjuvi |
| Genzyme Corporation | $378.64 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $361.83 | 2019-2023 | Epkinly, Imbruvica |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $332.43 | 2019-2025 | Keytruda, Lynparza |
| Shield Therapeutics INC | $321.45 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $277.93 | 2020-2025 | Ultomiris |
| Lilly USA, LLC | $269.78 | 2019-2024 | Verzenio, Jaypirca, Retevmo |
| Mirati Therapeutics, INC. | $266.29 | 2023-2024 | Krazati |
| Takeda Pharmaceuticals U.S.A., INC. | $255.39 | 2019-2025 | Alunbrig, Vpriv, Ninlaro |
| Eisai INC. | $239.44 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $228.95 | 2019-2025 | |
| Seagen INC. | $220.65 | 2019-2025 | Tukysa, Adcetris |
| Glaxosmithkline, LLC. | $201.00 | 2024-2025 | Ojjaara, Jemperli, Blenrep |
| Abbvie INC. | $196.99 | 2019-2025 | |
| Celgene Corporation | $193.46 | 2019-2023 | Pomalyst |
| Taiho Oncology, INC. | $191.96 | 2019-2025 | |
| Exelixis INC. | $172.75 | 2021-2025 | Cabometyx |
| Jazz Pharmaceuticals INC. | $143.86 | 2019-2025 | |
| Tersera Therapeutics LLC | $134.34 | 2019-2025 | Xermelo |
| Beone Medicines USA, INC. | $117.47 | 2025 | Tevimbra, Brukinsa |
| Genentech USA, INC. | $114.29 | 2019-2025 | Polivy |
| Emd Serono, INC. | $113.01 | 2022-2023 | Bavencio |
| Janssen Pharmaceuticals, INC | $105.24 | 2019-2024 | Xarelto |
| Comsort, INC | $100.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2021 | |
| Pharmaessentia USA Corporation | $99.88 | 2022-2025 | Besremi |
| Regeneron Healthcare Solutions, INC. | $98.14 | 2019-2024 | Libtayo |
| Sobi, INC | $97.93 | 2023-2025 | |
| Beigene USA, INC. | $96.61 | 2022-2025 | Brukinsa |
| Kyowa Kirin, INC. | $85.97 | 2019-2024 | Poteligeo |
| Blueprint Medicines Corporation | $71.09 | 2023-2024 | Ayvakit |
| Alnylam Pharmaceuticals INC. | $70.83 | 2021-2025 | Givlaari |
| Servier Pharmaceuticals LLC | $68.26 | 2022-2023 | |
| Morphosys, US INC. | $65.37 | 2022-2024 | Monjuvi |
| Stemline Therapeutics INC. | $64.85 | 2024-2025 | Orserdu |
| Kite Pharma, INC. | $55.71 | 2020-2023 | Yescarta |
| Helsinn Therapeutics (U.S.), INC. | $52.99 | 2019 | |
| Pharmacosmos Therapeutics INC. | $50.76 | 2023-2024 | Monoferric |
| Array Biopharma INC | $50.05 | 2024-2025 | Mektovi, Braftovi, Lorbrena |
| Acrotech Biopharma INC. | $48.35 | 2024 | Beleodaq |
| Clovis Oncology, INC. | $47.65 | 2019-2022 | |
| Novocure INC. | $46.43 | 2021-2025 | Optune Lua (Novottf-200t) |
| Puma Biotechnology, INC. | $44.12 | 2019-2022 | |
| Menarini Silicon Biosystems, INC. | $43.26 | 2025 | |
| Agios Pharmaceuticals, INC. | $40.26 | 2019-2025 | Pyrukynd |
| Coherus Oncology, INC. | $39.67 | 2022 | |
| Global Blood Therapeutics, INC. | $38.53 | 2020-2022 | |
| Aimmune Therapeutics, INC. | $38.00 | 2025 | Zenpep |
| G1 Therapeutics, INC. | $37.82 | 2022-2023 | Cosela |
| Tolmar Pharmaceuticals, INC. | $36.63 | 2019-2020 | |
| Legend Biotech USA INC. | $35.36 | 2024-2025 | Carvykti |
| Apellis Pharmaceuticals, INC. | $33.30 | 2022-2023 | |
| Argon Medical Devices, INC. | $33.22 | 2023 | Tlok |
| Argenx US, INC. | $32.42 | 2025 | Vyvgart Hytrulo |
| Immunocore Limited | $30.00 | 2025 | Kimmtrak |
| Cti Biopharma Corp. | $29.35 | 2023 | Vonjo |
| Tempus Ai, INC | $27.82 | 2024-2025 | Xt Cdx |
| Dova Pharmaceuticals | $24.04 | 2020 | |
| Immunogen, INC. | $23.67 | 2023 | Elahere |
| Karyopharm Therapeutics INC. | $20.35 | 2025 | Xpovio |
| Myovant Sciences INC. | $18.43 | 2022 | |
| Emmaus Medical, INC. | $17.10 | 2019 | |
| Dendreon Pharmaceuticals LLC | $16.11 | 2019 | |
| Portola Pharmaceuticals, LLC | $16.09 | 2020 | |
| Rigel Pharmaceuticals, INC. | $15.71 | 2023 | Tavalisse, Rezlidhia |
| Tesaro, INC. | $12.71 | 2019 | |
| Iovance Biotherapeutics, INC. | $6.20 | 2025 | Amtagvi |
Drugs and devices associated with these payments
Kisqali $1,635Enhertu $562Myrisk $422Fabhalta $421Accrufer $321Imbruvica $308Epkinly $269Krazati $266Onivyde $224Tukysa $204Verzenio $202Erleada $195Trodelvy $193Scemblix $191Ultomiris $175Padcev $170Lonsurf $168Inqovi $168Jaypirca $147Sarclisa $141Promacta $138Brukinsa $137Ojjaara $135Lynparza $134Lenvima $131Datroway $130Jakafi $129Zepzelca $125Cabometyx $121Nubeqa $121Xtandi $118Eliquis $114Ibrance $111Keytruda $103Ayvakit $102Vitrakvi $86.29Monjuvi $84.04Xofigo $78.73Tasigna $76.74Opdivo $76.27Carvykti $75.10Besremi $74.06Inlyta $72.79Vonjo $72.52Adcetris $68.16Elrexfio $67.89Talzenna $65.91Orserdu $64.85Stivarga $62.83Tevimbra $62.60Pomalyst $62.17Retevmo $61.45Tagrisso $61.34Alunbrig $57.50Doptelet $54.76Pemazyre $54.56Imfinzi $53.97Givlaari $53.77Tecvayli $50.81Monoferric $50.76Mektovi $50.05Braftovi $50.05Beleodaq $48.35Cellsearch $43.26Darzalex $42.05Xospata $40.87Libtayo $40.38Jemperli $39.93Vpriv $38.89Jevtana $38.52Piqray $38.24Zenpep $38.00Bavencio $37.50Tlok $33.22Ninlaro $33.14Vyvgart Hytrulo $32.42Somatuline Depot $31.99Optune Lua (Novottf-200t) $30.32Kimmtrak $30.00Orgovyx $29.59Bosulif $28.94Polivy $28.57Xt Cdx $27.82Talvey $27.42Lorbrena $27.38Rybrevant $27.21Fruzaqla $26.89Blenrep $26.45Xalkori $25.29Xermelo $23.92Elahere $23.67Xarelto $23.23Injectafer $23.20Tibsovo $22.68Nplate $22.20Vectibix $22.20Xgeva $22.20Oxbryta $22.11Yescarta $21.81Kyprolis $21.30
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Rybalova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.